Page last updated: 2024-11-03

procainamide and Brain Damage, Chronic

procainamide has been researched along with Brain Damage, Chronic in 1 studies

Procainamide: A class Ia antiarrhythmic drug that is structurally-related to PROCAINE.
procainamide : A benzamide that is 4-aminobenzamide substituted on the amide N by a 2-(diethylamino)ethyl group. It is a pharmaceutical antiarrhythmic agent used for the medical treatment of cardiac arrhythmias.

Brain Damage, Chronic: A condition characterized by long-standing brain dysfunction or damage, usually of three months duration or longer. Potential etiologies include BRAIN INFARCTION; certain NEURODEGENERATIVE DISORDERS; CRANIOCEREBRAL TRAUMA; ANOXIA, BRAIN; ENCEPHALITIS; certain NEUROTOXICITY SYNDROMES; metabolic disorders (see BRAIN DISEASES, METABOLIC); and other conditions.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
van Praag, HM1

Other Studies

1 other study available for procainamide and Brain Damage, Chronic

ArticleYear
[Psychopharmaca in the aged].
    Nederlands tijdschrift voor geneeskunde, 1977, Mar-26, Volume: 121, Issue:13

    Topics: Aged; Brain Damage, Chronic; Dementia; Dihydroergotoxine; Humans; Intracranial Arteriosclerosis; Men

1977